Nanotechnology ETF - TINY Nanotechnology ETF

ProShares Nanotechnology ETF seeks investment results, before fees and expenses, that track the performance of the Solactive Nanotechnology Index.

ProShares Nanotechnology ETF invests in companies that help businesses use nanoscale technology to transform lives and revolutionize industries.

  • From sunscreen nanoparticles to undetectable nanorobots monitoring your body’s health from the inside, production at the nanoscale lets companies manufacture smaller, smarter and more functional products.
  • Nano-sized objects are so small that they cannot be seen through a conventional microscope. For instance, the components of a nanorobot can be about one-millionth the size of the average ant.
  • As an industry, nanotechnology has experienced rapid growth. Emergen Research forecasts the global industry to reach $290 billion by 2028—an 18% annualized growth rate from 2021.
  • Read more about ProShares Nanotechnology ETF
  • Discover more ProShares thematic ETFs.
  • Get the latest insights on our thematic strategies.

Fund Snapshot

Ticker TINY
Intraday Ticker TINY.IV
CUSIP 74347G465
Inception Date 10/26/21
Expense Ratio 0.58%
NAV Calculation Time 4:00 p.m. ET
Distributions Quarterly

Fund Holdings Information as of 12/1/21

NOVAVAX INC 5.45%
ADVANCED MICRO DEVICES 5.22%
LAM RESEARCH CORP 5.19%
ONTO INNOVATION INC 5.00%
TOWER SEMICONDUCTOR LTD 4.78%
APPLIED MATERIALS INC 4.67%
KLA CORP 4.65%
ULTRA CLEAN HOLDINGS INC 4.50%
ENTEGRIS INC 4.45%
TAIWAN SEMICONDUCTOR-SP ADR 4.37%

Fund Country Weightings as of 12/1/21

UNITED STATES 64.98%
ISRAEL 6.85%
JAPAN 4.69%
TAIWAN 4.38%
NETHERLANDS 4.33%
SINGAPORE 3.57%
UNITED KINGDOM 3.24%
SOUTH KOREA 2.62%
CHINA 1.46%
GERMANY 0.84%

Price Information as of 12/1/21

NAV $43.06
NAV Change -$0.20
Market Price Closing $43.03
Market Price Closing Change -$0.22
Daily Trading Volume 5,903
30-Day Median Bid Ask Spread 0.23%
Sources: Emergen Research, "Nanotechnology Market Size," March 2021; Interesting Engineering, "Nanobots Will Be Flowing Through Your Body by 2030," November 2020